Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453277) titled 'Blood-Based Molecular Clock Biomarkers Predict Acute Ischemic Stroke Onset: A Prospective Observational Study' on March 1.
Study Type: Observational
Primary Sponsor: Izmir Katip Celebi University
Condition:
Emergency Medicine
Stroke Acute
Recruitment Status: Not recruiting
Date of First Enrollment: March 1, 2026
Target Sample Size: 80
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07453277
Published by HT Digital Content Services with permission from Health Daily Digest....